Company Lookup
Download Demo

Market News

This Month News

This Month News

send to a friend by email

JPH records net income of $1.60 million in Q1 2017


According to the financial statements of Jerusalem Pharmaceuticals JPH for Q1 2017, Net profit after tax of the period reached 1,605,998 USD Compared with Net Loss after tax (398,776) USD for 2016.Total assets of the company reached 57,266,218 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 8.11%.Total liabilities of the company reached 13,509,015 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net increase of 6.28%. Net ownership equity of the company reached 43,757,203 USD (Including Non-Controlling Interests of 482,438 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 8.69%.


Scarce liquidity in the PEX and 3G mobile networks in the West Bank by the end of January

launching 3G mobile networks in the west bank by the end of January

Relative quietness in the PEX with the increasing anticipation for the annual disclosures

WATANIYA discusses raising its paid-up capital to $293 million

The PEX opens the year 2018 in optimism

The PEX modifies AL-Quds Index composition for the year 2018



Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013